Symposia: Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acute Myeloid Malignancies, AML, Combination therapy, Apoptosis, Fundamental Science, Translational Research, Drug development, CHIP, Genomics, Hematopoiesis, Education, Diseases, Therapy sequence, Treatment Considerations, Myeloid Malignancies, Biological Processes, Molecular biology, Technology and Procedures, Gene editing, Study Population, Animal model
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acute Myeloid Malignancies, AML, Combination therapy, Apoptosis, Fundamental Science, Translational Research, Drug development, CHIP, Genomics, Hematopoiesis, Education, Diseases, Therapy sequence, Treatment Considerations, Myeloid Malignancies, Biological Processes, Molecular biology, Technology and Procedures, Gene editing, Study Population, Animal model
Monday, December 9, 2024: 10:30 AM-12:00 PM
Seaport Ballroom ABCD
(Manchester Grand Hyatt San Diego)
Moderators:
Maria L Amaya, MD, PhD, University of Colorado
and
Raphael Itzykson, INSERM U944
Disclosures:
Amaya: Bristol Myers Squibb: Honoraria. Itzykson: Abbvie: Research Funding; Advesya: Research Funding.
10:30 AM
10:45 AM
11:00 AM
11:30 AM
11:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH